Alterity Therapeutics Ltd
ASX:ATH

Watchlist Manager
Alterity Therapeutics Ltd Logo
Alterity Therapeutics Ltd
ASX:ATH
Watchlist
Price: 0.008 AUD
Market Cap: 87m AUD

Wall Street
Price Targets

ATH Price Targets Summary
Alterity Therapeutics Ltd

There are no price targets for ATH.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Alterity Therapeutics Ltd Competitors:
Price Targets
GLTO
Galecto Inc
35% Upside
SOBI
Swedish Orphan Biovitrum AB (publ)
10% Upside
VITR
Vitrolife AB
44% Upside
PRTA
Prothena Corporation PLC
125% Upside
GNS
Genus PLC
16% Upside
6160
Beigene Ltd
35% Upside
PBYI
Puma Biotechnology Inc
15% Downside
RARE
Ultragenyx Pharmaceutical Inc
150% Upside

Revenue
Forecast

Revenue Estimate
Alterity Therapeutics Ltd

For the last 13 years the compound annual growth rate for Alterity Therapeutics Ltd's revenue is 7%. The projected CAGR for the next 3 years is 345%.

7%
Past Growth
345%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Alterity Therapeutics Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Alterity Therapeutics Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ATH's stock price target?
Not Available

ATH doesn't have any price targets made by Wall Street professionals.

What is Alterity Therapeutics Ltd's Revenue forecast?
Projected CAGR
345%

For the last 13 years the compound annual growth rate for Alterity Therapeutics Ltd's revenue is 7%. The projected CAGR for the next 3 years is 345%.

Back to Top